Skip to main content

Advertisement

SpringerLink
Log in

Novel strategies in the management of chronic lymphocytic leukemia (CLL)

ASH meeting 2015

  • special report
  • Published:
memo - Magazine of European Medical Oncology Aims and scope Submit manuscript

Summary

This review discusses promising new approaches in the management of chronic lymphocytic leukemia (CLL) that were recently presented at the annual meeting of the American Society of Hematology meeting in 2015. In total, 405 abstracts concerning biological and clinical aspects of CLL were presented. The review concentrates on clinical data regarding improved treatment strategies for treatment-naïve patients as well as those with relapsed/refractory disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Author information

Authors and Affiliations

  1. Department of Internal Medicine I, Center for Oncology and Hematology, Wilhelminenspital, Montleartstrasse 37, 1160, Vienna, Austria

    Daniel Heintel

Authors
  1. Daniel Heintel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel Heintel.

Ethics declarations

Conflict of interest

D. Heintel received honoraria from Roche, Gilead, Abbvie, Takeda, Janssen, Mundipharma, Celgene.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Heintel, D. Novel strategies in the management of chronic lymphocytic leukemia (CLL). memo 9, 111–115 (2016). https://doi.org/10.1007/s12254-016-0285-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12254-016-0285-1

Keywords

Search

Navigation